- Home
- IOTR vs ANTX Comparison
IOTR vs ANTX Comparison
Compare IOTR & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOTR
- ANTX
- Stock Information
- Founded
- IOTR 2019
- ANTX 2017
- Country
- IOTR Singapore
- ANTX United States
- Employees
- IOTR N/A
- ANTX N/A
- Industry
- IOTR
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- IOTR
- ANTX Health Care
- Exchange
- IOTR NYSE
- ANTX Nasdaq
- Market Cap
- IOTR 11.5M
- ANTX 33.2M
- IPO Year
- IOTR 2025
- ANTX 2022
- Fundamental
- Price
- IOTR $0.47
- ANTX $1.07
- Analyst Decision
- IOTR
- ANTX Buy
- Analyst Count
- IOTR 0
- ANTX 2
- Target Price
- IOTR N/A
- ANTX $2.00
- AVG Volume (30 Days)
- IOTR 693.0K
- ANTX 71.9K
- Earning Date
- IOTR 01-01-0001
- ANTX 08-12-2025
- Dividend Yield
- IOTR N/A
- ANTX N/A
- EPS Growth
- IOTR N/A
- ANTX N/A
- EPS
- IOTR N/A
- ANTX N/A
- Revenue
- IOTR $10,478,550.00
- ANTX N/A
- Revenue This Year
- IOTR N/A
- ANTX N/A
- Revenue Next Year
- IOTR N/A
- ANTX N/A
- P/E Ratio
- IOTR N/A
- ANTX N/A
- Revenue Growth
- IOTR 22.27
- ANTX N/A
- 52 Week Low
- IOTR $0.31
- ANTX $0.87
- 52 Week High
- IOTR $5.98
- ANTX $2.73
- Technical
- Relative Strength Index (RSI)
- IOTR N/A
- ANTX 45.56
- Support Level
- IOTR N/A
- ANTX $1.05
- Resistance Level
- IOTR N/A
- ANTX $1.16
- Average True Range (ATR)
- IOTR 0.00
- ANTX 0.03
- MACD
- IOTR 0.00
- ANTX 0.00
- Stochastic Oscillator
- IOTR 0.00
- ANTX 18.87
About IOTR IOTHREE LIMITED
iOThree Ltd is a provider of maritime digital technologies, including satellite connectivity and digitalization solutions in Singapore, focused on facilitating the maritime industry towards digital transformation. It offers shipboard infrastructure to customers by designing and installing the necessary satellite connectivity solution, IT equipment, shipboard equipment (such as equipment relating to navigation systems, automatic identification system, etc.), and JARVISS, a digitalization platform on the vessels of customers. The group's operating segments are: Satellite connectivity solution, which generates key revenue, and Digitalization and other solution. Geographically, it generates maximum revenue from Singapore, and rest from Israel, Malaysia, Vietnam, Thailand, and other regions.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.